Requirement for mevalonate in the control of proliferation of human breast cancer cells.

Abstract:

:The proliferative rate as well as the activity of 3-hydroxy-3-methylglutaryl CoA (HMG CoA) reductase, which regulates de novo synthesis of mevalonate, was comparable in the two human breast cancer cell lines Hs578T and MDA-231 when cultured in the presence of serum. Upon treatment with mevinolin (an HMG CoA reductase inhibitor) the proliferation of the cell lines was depressed with similar dose response kinetics. A depression of the enzymatic activity to a level of 1-1.5 pmol mevalonate/min/mg protein decreased DNA-synthesis by approximately 90%. In contrast, at slightly higher enzymatic activities, ie 2-2.5 pmol/min/mg protein, there was only a mild decrease in DNA-synthesis. Addition of mevalonate to a final concentrations of 0.77 mM completely prevented the mevinolin-induced block on cell proliferation in both cell lines. Exposure to serum-free medium caused by itself a depression of HMG CoA reductase activity to 2.5-3 pmol/min/mg protein in both cell lines. Whereas the proliferation of MDA-231 was not inhibited at all by serum depletion, this treatment decreased DNA-synthesis in Hs578T by nearly 80%. Interestingly, the addition of mevalonate also prevented this growth inhibition in Hs578T, irrespective of whether mevinolin was present or not. However, this required a 30-fold increase in the mevalonate concentration (23.1 mM) as compared to MDA-231. The present data indicate that mevalonate is not only necessary for cell proliferation, but also that mevalonate is involved in the serum-dependent control of cell proliferation in serum-sensitive cells. In this respect, serum seems to affect the utilization of mevalonate in the formation of mevalonate-derived growth-regulatory molecules, rather than regulating the de novo synthesis of mevalonate.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Wejde J,Blegen H,Larsson O

subject

Has Abstract

pub_date

1992-03-01 00:00:00

pages

317-24

issue

2

eissn

0250-7005

issn

1791-7530

journal_volume

12

pub_type

杂志文章
  • Epidermal growth factor receptor changes during breast cancer metastasis.

    abstract:BACKGROUND:Since the anti-HER2 monoclonal antibody trastuzumab made its triumphant advance into breast cancer therapy, new selective agents, including pan-HER inhibitors are entering clinical practice. MATERIALS AND METHODS:This study investigates the expression of the four HER-family members, HER1-4, in 48 primary br...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fuchs IB,Siemer I,Bühler H,Schmider A,Henrich W,Lichtenegger W,Schaller G,Kuemmel S

    更新日期:2006-11-01 00:00:00

  • Sunitinib re-challenge in metastatic renal cell carcinoma treated sequentially with tyrosine kinase inhibitors and everolimus.

    abstract::Therapy of patients with metastatic renal cell carcinoma (mRCC) requires sequential use of several agents with different mechanisms and minimal cross-resistance between the different agents. Tyrosine kinase inhibitors (TKIs) and mammalian target of rapamycin (mTOR) inhibitors prolong progression-free survival (PFS) in...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Paule B,Brion N

    更新日期:2011-10-01 00:00:00

  • Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases.

    abstract:AIM:The aim of the present study was to investigate the prognostic impact of central nervous system metastases (CNS) after acquired resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) in EGFR-mutant non-small cell lung cancer (NSCLC). PATIENTS AND METHODS:We defined CNS-collapse as de...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hata A,Katakami N,Yoshioka H,Takeshita J,Tanaka K,Masago K,Fujita S,Kaji R,Imai Y,Monden K,Matsumoto T,Nagata K,Otsuka K,Tachikawa R,Tomii K,Kunimasa K,Iwasaku M,Nishiyama A,Ishida T,Nishimura Y

    更新日期:2015-02-01 00:00:00

  • Metastatic breast cancer patients failing first-line, anthracycline-containing chemotherapy: is further therapy of benefit?

    abstract::During the last 50 years median survival for metastatic breast cancer has not varied and remains 2-3.5 years. To assess the clinical benefit of salvage systemic therapy a retrospective analysis of metastatic breast cancer patients all homogeneously treated with a commonly used first-line anthacycline-containing cytoto...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Campora E,Gardin G,Gasco M,Rosso R,Santi L

    更新日期:1999-07-01 00:00:00

  • Oral cancer in Swedish snuff dippers.

    abstract::Over recent decades there has been debate over whether or not Swedish snuff is carcinogenic in humans. Animal studies and molecular biological and experimental studies have shown the carcinogenic potential of Swedish snuff, but this has not been proved in prospective randomized studies. We present a case series of pat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hirsch JM,Wallström M,Carlsson AP,Sand L

    更新日期:2012-08-01 00:00:00

  • Release of daunorubicin from polymethylmethacrylate for the improvement of the local growth control of bone metastasis animal experiments.

    abstract::Bone metastases are a sign of advanced tumor disease. Surgical therapy is only occasionally curative. Therefore, the therapeutic goals are a limited surgical excision, immediate mobilization, effective stabilization and the avoidance of local recurrence. We investigated the effect of the anthracycline daunorubicin (DN...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fröschle GW,Mählitz J,Langendorff HU,Achilles E,Pollock J,Jungbluth KH

    更新日期:1997-03-01 00:00:00

  • Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb.

    abstract::MOv18, a non-internalizing monoclonal antibody (MAb) with restricted tumor specificity, was conjugated to ricin toxin (RT). According to their ability to bind to galactose residues of Sepharose 6B, the immunoconjugates were fractionated into Bound and Unbound MOv18-RT. The two conjugates could be distinguished by SDS-...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cogliati T,Brusa P,Canevari S,Caldera M,Mezzanzanica D,Dosio F,Cattel L,Colnaghi MI

    更新日期:1991-01-01 00:00:00

  • Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial.

    abstract:PURPOSE:To determine the tolerability and efficacy of the combination of gefitinib with gemcitabine plus vinorelbine in metastatic breast cancer (MBC) patients, pretreated with anthracyclines and taxanes. PATIENTS AND METHODS:Women with measurable MBC pretreated with anthracycline- and taxane-based chemotherapy receiv...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gioulbasanis I,Saridaki Z,Kalykaki A,Vamvakas L,Kalbakis K,Ignatiadis M,Amarantidis K,Kakolyris S,Georgoulias V,Mavroudis D

    更新日期:2008-09-01 00:00:00

  • Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature.

    abstract::The use of salvage chemotherapy in advanced non small cell lung cancer (NSCLC) is controversial. However, many patients need to be treated in order to achieve relief of their symptoms. Docetaxel (taxotere) is one of the most active drugs for the treatment of advanced NSCLC and several studies have also shown its effec...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究,评审

    doi:

    authors: Gridelli C,Frontini L,Barletta E,Rossi A,Barzelloni ML,Scognamiglio F,Guida C,Gatani T,Fiore F,De Bellis M,Marfella A,Manzione L

    更新日期:2000-03-01 00:00:00

  • Activation of DNA damage response by antitumor therapy counteracts the activity of vinca alkaloids.

    abstract:BACKGROUND/AIM:Anthracyclines have been proven able to reduce the activity of vinca alkaloids by induction of cell-cycle arrest. The present study aims at identifying the critical initiation steps of signal transduction which transduce the inhibitory effects on the cytotoxicity of vinca alkaloids. MATERIALS AND METHOD...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ehrhardt H,Pfeiffer S,Schrembs D,Wachter F,Grunert M,Jeremias I

    更新日期:2013-12-01 00:00:00

  • Multiple extractions of hormone receptor from rabbit uteri and human breast tumors.

    abstract::The cytosol hormone receptors were extracted from rabbit uteri and human tumors with tris buffer systems for three consecutive homogenization and centrifugation processes to obtain three cytosols C-1, C-2, and C-3. The assay results evaluated revealed that minimal to tremendous amounts of receptor activities were pres...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chen YM,Rice RG,Vaughn CB

    更新日期:1985-07-01 00:00:00

  • Frequent high expression of bax pro-apoptotic protein in non-small cell lung cancer.

    abstract::Bax, bcl-2 and their homologues regulate a distal step in an evolutionary very well conserved pathway of apoptotic cell death. It plays a crucial role in the balance between proliferation rate and cell viability. Thus in the last years the attention of the scientific community towards these proteins has remarkably inc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Caputi M,Groeger AM,Esposito V,De Luca A,Murabito M,Tahir T,Giordano GG,Baldi F,Giordano A,Wolner E

    更新日期:1999-01-01 00:00:00

  • Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin.

    abstract::Ras proteins must be isoprenylated at a conserved cysteine residue near the carboxyl terminus (Cys-186 in mammalian Ras p21 proteins) in order to extend their biological activity. Previous studies have indicate an intermediate in the mevalonate pathway, most likely farnesyl pyrophosphate, is the donor of this isopreny...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chen X,Hasuma T,Yano Y,Yoshimata T,Morishima Y,Wang Y,Otani S

    更新日期:1997-07-01 00:00:00

  • A phase III randomized study comparing paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with advanced ovarian cancer.

    abstract:AIM:To assess progression-free survival (PFS) and overall survival (OS) in patients with advanced epithelial ovarian cancer receiving the combination of cisplatin (75 mg/m(2) i.v.) and cyclophosphamide (700 mg/m(2) i.v.) (CP), or the combination of paclitaxel (175 mg/m2) followed by cisplatin (75 mg/m2) (TP). PATIENTS...

    journal_title:Anticancer research

    pub_type: 杂志文章,随机对照试验

    doi:

    authors: Mouratidou D,Gennatas C,Michalaki V,Papadimitriou A,Andreadis CH,Sykiotis C,Tsavaris N

    更新日期:2007-01-01 00:00:00

  • Stilbenes as multidrug resistance modulators and apoptosis inducers in human adenocarcinoma cells.

    abstract:BACKGROUND:The search for promising modulators of cancer multidrug resistance (MDR) that are able to reduce the activity of P-glycoprotein, thus restoring the cytotoxicity of anticancer drugs, is ongoing. The identification of compounds that overcome the apoptosis deficiency that frequently accompanies MDR is also of g...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Wesolowska O,Wisniewski J,Bielawska-Pohl A,Paprocka M,Duarte N,Ferreira MJ,Dus D,Michalak K

    更新日期:2010-11-01 00:00:00

  • The tyrosine kinase inhibitor AG490 inhibits growth of cancer cells and activates ERK in LS174T and HT-29 cells.

    abstract:BACKGROUND:The activity of tyrosine kinases, although strictly regulated in normal cells, is often disturbed in cancer cells. The inhibition of a tyrosine kinase could be a target for treating cancer. MATERIALS AND METHODS:The colon cancer cell lines LS174T and HT-29 and the lung cancer cell line NCI-H292 were used. T...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Saito K,Iwashita J,Murata J,Abe T

    更新日期:2006-03-01 00:00:00

  • Effects of Pre-surgical Vitamin D Supplementation and Ketogenic Diet in a Patient with Recurrent Breast Cancer.

    abstract:BACKGROUND:A woman, mother of one at the age of 19 years, was diagnosed with mammary adenocarcinoma in the right breast in 1985 at the age of 37 years. The patient underwent surgery (quadrantectomy), lymphadenectomy and radiotherapy. In 1999, an adenocarcinoma was diagnosed in the left breast, followed by adequate rese...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Branca JJ,Pacini S,Ruggiero M

    更新日期:2015-10-01 00:00:00

  • Prognostic Impact of Proximal Versus Distal Localization in Extremity Long Bone Osteosarcomas.

    abstract:BACKGROUND/AIM:This study aimed to identify the prognostic factors and outcomes of osteosarcoma (OS) located in proximal versus distal extremity long bones. PATIENTS AND METHODS:A nationwide cohort comprising all Norwegian high-grade OSs in extremity long bones between 1982 and 2009 was investigated. RESULTS:The univ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13365

    authors: Berner K,Bruland ØS

    更新日期:2019-05-01 00:00:00

  • Color-coded Imaging Enables Fluorescence-guided Surgery to Resect the Tumor Along with the Tumor Microenvironment in a Syngeneic Mouse Model of EL-4 Lymphoma.

    abstract:BACKGROUND/AIM:Fluorescence-guided surgery (FGS) of cancer is an emerging technology. We have previously shown the importance of resecting both the tumor and the tumor microenvironment (TME) for curative FGS. We also previously developed a syngeneic model using the mouse lymphoma cell line EL-4, expressing red fluoresc...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.10988

    authors: Hasegawa K,Suetsugu A,Nakamura M,Matsumoto T,Kunisada T,Shimizu M,Saji S,Moriwaki H,Bouvet M,Hoffman RM

    更新日期:2016-09-01 00:00:00

  • Human bladder carcinoma cells with an unusual pattern of in vitro growth: transition from nonproliferative spheroids to active monolayer growth upon interaction with tumor-derived fibroblasts.

    abstract::A new transitional cell carcinoma cell line, BCCA-1, derived from a primary urinary bladder carcinoma, was characterized with respect to the growth patterns of in vitro culture, xenotransplantability in SCID mice and immunophenotypic profile. The most unusual finding was a strong tendency of forming many aggregates (m...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chuang CK,Liao SK

    更新日期:2000-03-01 00:00:00

  • Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.

    abstract::P-glycoprotein (P-gp) and multidrug resistance related protein (MRP) overexpression is often responsible of the development of multidrug resistance in cancer therapy. These proteins are also expressed in normal tissues, where their physiological role is related to the extrusion of endogenous toxins or to secretory fun...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rosati A,Decorti G,Klugmann FB,Candussio L,Granzotto M,Melato M,Giraldi T

    更新日期:2000-09-01 00:00:00

  • Cell-cycle analysis and apoptosis-associated proteins in cervical lesions of Brazilian women.

    abstract:AIM:The aim of the present study was to detect the relative expressions of p53, p21(Waf1/Cip1), p27(Kip1) Bcl-2 and cleaved caspase-3 in cervical lesion samples from Brazilian women by immunohistochemistry. MATERIALS AND METHODS:A total of 230 cervical biopsies in paraffin-embedded blocks were studied: 43 were invasiv...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Dobo C,Oshima CT,De Oliveira Lima F,Gomes TS,Stávale JN,Arias V,Ribeiro DA,Focchi GR

    更新日期:2014-06-01 00:00:00

  • Tpot and head and neck cancer: where are we now?

    abstract::Cell proliferation measurements using bromodeoxyuridine administration to patients and flow cytometry to measure Tpot in head and neck cancer are discussed. Several hundred patients have now been assessed and the majority of studies suggest that this group of tumours represent a relatively fast proliferating site with...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Wilson GD

    更新日期:1998-11-01 00:00:00

  • Preliminary Observation on the Cytotoxic Activity of New Chlorophyllin Derivative RCD on Human Tumour Cell Lines In Vitro.

    abstract:BACKGROUND:Chlorophyllin is used in traditional Chinese medicine because of its anticancer properties. This article describes the preparation and cytotoxic activity of a reduced chlorophyllin derivative (RCD) on tumour cell lines. MATERIALS AND METHODS:RCD was prepared by reducing chlorophyllin with lithium aluminium ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13287

    authors: Pinelli A,Ferrario P,Trivulzio S

    更新日期:2019-04-01 00:00:00

  • Underutilization of the CROSS Regimen Among US Radiation Oncologists: A National Survey of Practice Patterns.

    abstract:AIM:To examine patterns of clinical practice in locally advanced esophageal cancer among US radiation oncologists after publication of the CROSS trial. MATERIALS AND METHODS:US radiation oncologists were surveyed on 13 questions pertaining to the management of esophageal cancer. Respondents' demographics and their cli...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12996

    authors: Elliott DA,Rana SR,Nabavizadeh N,Chen Y,Kusano A,Holland JM,Mitin T

    更新日期:2018-11-01 00:00:00

  • Chromosomal characterization and isoenzyme pattern of non-malignant and malignant human urothelial cell lines.

    abstract::The karyotypes and selected isoenzymes of five cell lines, HU 961b, HU 1922, HU 609, HCV-29 and HU 1703 He, were characterized. These cell lines were derived either from histologically normal human urothelial cells or from transitional cell carcinoma (TCC) of the urinary bladder. They displayed different life span in ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Debiec-Rychter M,Christensen B,Kieler J,Wang CY

    更新日期:1986-09-01 00:00:00

  • Debulking Surgery for Clear Cell Carcinoma of the Ovary - A Case Report and Literature Review.

    abstract::Ovarian clear cell carcinoma represents a distinct histopathological subtype of epithelial ovarian cancer, with poor outcomes, especially in cases diagnosed in advanced stages of disease. However, even in these cases, it seems that the most effective treatment remains debulking surgery to no residual disease. We prese...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:10.21873/anticanres.12008

    authors: Bacalbasa N,Balescu I,Filipescu A

    更新日期:2017-10-01 00:00:00

  • Antitumor activity of norspermidine, a structural homologue of the natural polyamine spermidine.

    abstract::The structural specificities of the natural polyamines putrescine (Put), spermidine (Spd) and spermine (Spm) for cell growth are rather stringent, suggesting that appropriate structural analogues of these polycations could serve as potential antineoplastic agents via polyamine antagonism. Norspermidine (Nspd), a homol...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Prakash NJ,Bowlin TL,Davis GF,Sunkara PS,Sjoerdsma A

    更新日期:1988-07-01 00:00:00

  • Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma.

    abstract::In human colorectal tissue samples, the gene expressions of 4 coactivators, p300, pCAF, TIF-2 and TRAP 220, and 7 corepressors, N-CoR, REA, MTA1, MTA1L1, HDAC1, HDAC2 and HDAC3, linked to estrogen receptors (ER), were revealed by traditional RT-PCR. Cofactors ERalpha, ERbeta and ERRalpha mRNA levels were then measured...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Giannini R,Cavallini A

    更新日期:2005-11-01 00:00:00

  • Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted Therapies.

    abstract:AIM:This study aimed at exploring several brain metastatic prognostic scores in patients with renal cell carcinoma. PATIENTS AND METHODS:We retrospectively analyzed data of 93 metastatic renal cell carcinoma patients who were diagnosed with brain metastases between October 2005 and July 2016 who received targeted ther...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:10.21873/anticanres.13431

    authors: El Ali Z,Rottey S,Barthelemy P,Kotecki N,VAN Paemel R,Devrient D,Awada A,Gil T,Pannier D,Ryckewaert T,Waisse W,Clavier JB,Penel N,Vermassen T

    更新日期:2019-06-01 00:00:00